Key result
Ventricular arrhythmia is linked to ~3.7-fold higher odds of cardiogenic shock in STEMI.
Why the study?
Contemporary local data on cardiogenic shock in patients with acute STEMI in Saudi Arabia are limited despite a younger population and higher diabetes burden compared to Western cohorts.
Cohort (n=878)
No
In a contemporary Saudi STEMI cohort presenting at a younger age with a high burden of diabetes, cardiogenic shock remained frequent (9.1%) but was driven by atypical predictors like dyslipidemia and arrhythmia rather than classical Western predictors like advanced age.
Ventricular arrhythmia and dyslipidemia may flag cardiogenic shock risk in younger Saudi STEMI patients; challenges consensus on classical predictors and leaves open prospective validation.
Background: Cardiogenic shock (CS) is the leading cause of mortality in ST-segment elevation myocardial infarction (STEMI). Patients with acute coronary syndrome in Saudi Arabia present a decade younger than Western cohorts and have a higher diabetes burden, yet contemporary local data on CS are limited. We aimed to determine the incidence, characteristics, and predictors of CS in a Saudi STEMI cohort. Methods: Single-center retrospective cohort study of consecutive adult patients with acute STEMI admitted to King Abdulaziz Cardiac Center, Riyadh, from January 2019 to December 2024. CS was defined by the SHOCK trial criteria. Univariate and multivariate logistic regression identified independent predictors. Results: A total of 878 patients were included (mean age 57.2 ± 13.6 years; 86.6% male); 80 (9.1%) developed CS. Compared with patients without CS, those with CS had a higher prevalence of dyslipidemia (58.8% vs. 44.6%, p = 0.016) and ventricular arrhythmia (17.5% vs. 5.5%, p < 0.001), higher peak troponin and N-terminal pro-B-type natriuretic peptid, and lower hemoglobin, sodium, potassium, and estimated glomerular filtration rate. No differences were observed in age, sex, hypertension, diabetes, or infarct location. In multivariate analysis, independent predictors of CS were female sex odds ratio (OR 0.18, 95% confidence intervals 0.06-0.52), dyslipidemia (OR 2.39, 1.22-4.70), arrhythmia (OR 3.69, 1.63-8.37), peak troponin (p = 0.040), peak blood urea nitrogen (OR 1.05, 1.01-1.08), nadir hemoglobin (OR 0.97, 0.96-0.99), and nadir potassium (OR 0.16, 0.07-0.34). Conclusion: CS occurred in 9.1% of this contemporary Saudi STEMI cohort. The predictors that emerged were not the classical Western ones; larger multicenter studies should confirm these findings and inform regional risk stratification.
No takes yet. Share an insight, caveat, or question.
Aljizeeri et al. (2026) conducted a cohort in Acute ST-segment elevation myocardial infarction (STEMI) (n=878). Ventricular arrhythmia vs. No ventricular arrhythmia was evaluated on Development of cardiogenic shock (OR 3.69, 95% CI 1.63-8.37, p=0.002). Ventricular arrhythmia (OR 3.69) and dyslipidemia (OR 2.39) emerged as strong independent predictors of cardiogenic shock in a Saudi STEMI cohort, whereas classical predictors like age and diabetes did not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: